Brief: Interpace Biosciences Q2 Revenue USD 11.026 Million

Interpace Biosciences

09/08/2023 17:30

Aug 09 (Reuters) - Interpace Biosciences Q2 net income continuing operations
USD 395 thousand.
* Q2 net income USD 175 thousand
* Q2 operating expenses USD 6.003 million
* Q2 operating income USD 832 thousand
* Q2 gross profit USD 6.835 million